Storia della carriera di Klaus B. Kepper
Precedenti posizioni note di Klaus B. Kepper
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MIRATI THERAPEUTICS | Direttore Finanziario/CFO | 01/10/2000 | 14/03/2013 |
| Smith & Nephew Canada | Direttore Finanziario/CFO | 01/01/1989 | 01/01/1995 |
| Segretario Aziendale | 01/01/1989 | 01/01/1995 | |
| Treasurer | 01/01/1989 | 01/01/1995 | |
| SMITH & NEPHEW PLC | Corporate Officer/Principal | - | - |
Formazione di Klaus B. Kepper
| Concordia University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Canada | 3 |
| Stati Uniti | 2 |
| Regno Unito | 2 |
Posizioni
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 1 |
| Corporate Secretary | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SMITH & NEPHEW PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
| Smith & Nephew Canada |
- Borsa valori
- Insiders
- Klaus B. Kepper
- Esperienza
